Multiple sclerosis (MS) is the commonest disabling neurological condition to afflict young
adults and therefore has a high social burden. Over several decades, there has been a …

Purpose of this Review: This article is a systematic review on the influence pregnancy has
on multiple sclerosis and the resulting impact of disease-modifying therapies. Findings …

Background and Objectives Several studies have shown an increased risk of relapse after in
vitro fertilization (IVF) in women with multiple sclerosis (MS), especially when a …

Abstract Background Pregnancy in Multiple Sclerosis (MS) has been a controversial issue,
without international standardized treatment recommendations. The goal of our study was to …

Multiple sclerosis (MS) is a one of the group of diseases labeled as “common complex”.
Virtually all common complex traits, genetic and environmental components have important …

Introduction Interferon beta (IFN beta) preparations are an established group of drugs used
for immunomodulation in patients with multiple sclerosis (MS). Subcutaneously (sc) applied …

Background: Safety data on disease-modifying therapies (DMTs) for relapsing multiple
sclerosis (RMS) during breastfeeding are limited. Objective: Assess safety outcomes for …

Pregnancy represents a physiological transitory state of immune tolerance to avoid the
rejection of the foetus, and concomitantly of stabilisation of many autoimmune diseases …

Background: There is a paucity of information on maternal multiple sclerosis (MS) and risk of
adverse pregnancy and perinatal outcomes. Objective: The aim of this study was to …

Background: Although effective contraception is strongly recommended during the therapy
of women with multiple sclerosis (MS) with some immunomodulatory drugs, unplanned …